Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Reinfections and Long COVID in the Post-Omicron Phase of the Pandemic
Fotini Boufidou, Snežana Medić, Vicky Lampropoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12962-12962
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Roxana Gheorghiţă, Iuliana Șoldănescu, Andrei Lobiuc, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Long COVID or Post-COVID-19 Condition: Past, Present and Future Research Directions
César Fernández‐de‐las‐Peñas, Arkiath Veettil Raveendran, Rocco Giordano, et al.
Microorganisms (2023) Vol. 11, Iss. 12, pp. 2959-2959
Open Access | Times Cited: 22
An intersectional analysis of long COVID prevalence
Jennifer Cohen, Yana van der Meulen Rodgers
International Journal for Equity in Health (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 21
Patients with unmet social needs are at higher risks of developing severe long COVID-19 symptoms and neuropsychiatric sequela
Anna Eligulashvili, Megan Darrell, Moshe Gordon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Vaccines for the Elderly and Vaccination Programs in Europe and the United States
Cleo Anastassopoulou, Stefanos Ferous, Snežana Medić, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 566-566
Open Access | Times Cited: 6
SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort study
Tesleem Kayode Babalola, Sean Clouston, Zennur Sekendiz, et al.
The Lancet Regional Health - Americas (2025) Vol. 42, pp. 100984-100984
Closed Access
Positionspapier zum Post-COVID-Syndrom
Elisabeth Schieffer, Denise Hilfiker‐Kleiner, Axel Schlitt, et al.
Deleted Journal (2025)
Closed Access
Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics
Grant Talkington, Paresh Kolluru, Timothy E. Gressett, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Increased Risk of Hospitalization for Various Disorders After COVID-19 Infection: A Cohort Study of the UK Biobank Spanning over a hundred Disease Categories
Yong Xiang, Ruoyu Zhang, Jinghong Qiu, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 5
Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19
Gregory P. Williams, Esther Dawen Yu, K. I. Shapiro, et al.
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110770-110770
Closed Access | Times Cited: 3
Animal models of Long Covid: A hit-and-run disease
Alexandra Schaefer, Sarah R. Leist, John M. Powers, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 773
Open Access | Times Cited: 3
Pharmacological evaluation of vitamin D in COVID-19 and long COVID-19: recent studies confirm clinical validation and highlight metformin to improve VDR sensitivity and efficacy
Adel A. Gomaa, Yasmin A. Abdel-Wadood, Romany H. Thabet, et al.
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 249-271
Open Access | Times Cited: 8
Seroprevalence of IgM/IgG and Neutralizing Antibodies against SARS-CoV-2 in Unvaccinated Young Adults from Mexico Who Reported Not Having Had a Previous COVID-19 Infection
Diana Lourdes Padilla-Bórquez, Mónica Guadalupe Matuz-Flores, Jorge Hernández‐Bello, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2024) Vol. 2024, pp. 1-8
Open Access | Times Cited: 2
Investigating ABO Blood Groups and Secretor Status in Relation to SARS-CoV-2 Infection and COVID-19 Severity
Stefanos Ferous, Nikolaos Siafakas, Fotini Boufidou, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 4, pp. 346-346
Open Access | Times Cited: 2
The importance of including Long COVID outcomes when developing novel treatments for acute COVID-19
Chloe Connor, Holly A. Taylor
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 2
Challenges and opportunities in long COVID research
Rebecca E. Hamlin, Catherine A. Blish
Immunity (2024) Vol. 57, Iss. 6, pp. 1195-1214
Closed Access | Times Cited: 2
Likelihood of Post-COVID Condition in people with hybrid immunity; data from the German National Cohort (NAKO);
Rafael Mikolajczyk, Sophie Diexer, Bianca Klee, et al.
Journal of Infection (2024) Vol. 89, Iss. 2, pp. 106206-106206
Closed Access | Times Cited: 2
An updated meta-analysis of Chinese herbal medicine for the prevention of COVID-19 based on Western-Eastern medicine
Siying Hu, Dan Luo, Qikui Zhu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 7
Comparison of post-acute sequelae following hospitalization for COVID-19 and influenza
Ting-Hui Liu, Po‐Yu Huang, Jheng‐Yan Wu, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein S1 Induces Methylglyoxal-Derived Hydroimidazolone/Receptor for Advanced Glycation End Products (MG-H1/RAGE) Activation to Promote Inflammation in Human Bronchial BEAS-2B Cells
Dominga Manfredelli, Marilena Pariano, Claudio Costantini, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14868-14868
Open Access | Times Cited: 5
Post-COVID Recovery is More Likely after an Infection with the SARS-CoV-2 Omicron Variant: A Population-Based Cohort Study
Laura Pfrommer, Sophie Diexer, Bianca Klee, et al.
(2024)
Closed Access | Times Cited: 1
Clinical Features and Vaccination Effects among Children with Post-Acute Sequelae of COVID-19 in Taiwan
Yu‐Lung Hsu, Pei‐Chi Chen, Yi‐Fen Tsai, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 910-910
Open Access | Times Cited: 1
Post-COVID recovery is faster after an infection with the SARS-CoV-2 Omicron variant: a population-based cohort study
Laura Rebecca Pfrommer, Sophie Diexer, Bianca Klee, et al.
Infection (2024)
Open Access | Times Cited: 1
COVID-19 and the Postviral Syndrome of Long COVID: Where We Have Come from and Where We Are Going
Susan A. Taylor, Nancy J. Smyth
Health & Social Work (2024) Vol. 49, Iss. 2, pp. 71-75
Closed Access
Page 1 - Next Page

Scroll to top